Han M, Sternberg P W
Howard Hughes Medical Institute, Division of Biology, California Institute of Technology, Pasadena 91125.
Genes Dev. 1991 Dec;5(12A):2188-98. doi: 10.1101/gad.5.12a.2188.
The let-60 gene of Caenorhabditis elegans controls the choice between vulval and hypodermal differentiation in response to an inductive signal from the gonad. let-60 encodes a ras protein that acts downstream of the let-23 receptor tyrosine kinase in a signal transduction pathway. Dominant-negative mutations of let-60 [let-60(dn)] cause a reduction of the gene activity in let-60(dn)/+ heterozygotes and a vulva-less mutant phenotype. We have found that nine let-60(dn) mutations cause replacements of conserved residues. Four are in two novel positions; others are in positions known previously to cause dominant-negative mutations in mammalian cells. The locations of these lesions suggest that they disrupt the ability of the ras protein to bind guanine nucleotides. Four let-60(dn) mutant genes were introduced into wild-type animals in the form of extrachromosomal arrays and were found to generate three dominant phenotypes--lethality, vulva-less, or multivulva--depending on gene dose and alleles. The dominant lethality caused by high-dose transgenic let-60(dn) genes suggests a toxic effect of these mutant genes in early development. The dominant-negative effects of these mutations in heterozygotes are likely to be caused by competition between let-60(dn) and let-60(+) protein for a positive regulator. All let-60(dn) mutations interfere with let-60(+) activity, but some alleles have partial constitutive activity, suggesting that the ability to interact with the activator is separable from the ability to exert a physiological effect (stimulation of vulval differentiation). These dn mutations might be useful for interfering with ras-mediated signal transduction pathways in other multicellular organisms.
秀丽隐杆线虫的let-60基因可响应来自性腺的诱导信号,控制外阴和皮下组织分化的选择。let-60编码一种Ras蛋白,该蛋白在信号转导途径中位于let-23受体酪氨酸激酶的下游。let-60的显性负性突变[let-60(dn)]会导致let-60(dn)/+杂合子中基因活性降低,并产生无外阴突变表型。我们发现,九个let-60(dn)突变导致保守残基的替换。其中四个位于两个新位置;其他位于先前已知在哺乳动物细胞中会导致显性负性突变的位置。这些损伤的位置表明它们破坏了Ras蛋白结合鸟嘌呤核苷酸的能力。四个let-60(dn)突变基因以染色体外阵列的形式导入野生型动物中,发现会产生三种显性表型——致死性、无外阴或多外阴——这取决于基因剂量和等位基因。高剂量转基因let-60(dn)基因引起的显性致死性表明这些突变基因在早期发育中有毒性作用。这些突变在杂合子中的显性负性效应可能是由let-60(dn)和let-60(+)蛋白竞争正调节因子引起的。所有let-60(dn)突变都会干扰let-60(+)的活性,但一些等位基因具有部分组成型活性,这表明与激活剂相互作用的能力与发挥生理效应(刺激外阴分化)的能力是可分离的。这些dn突变可能有助于干扰其他多细胞生物中Ras介导的信号转导途径。